🇺🇸 FDA
Patent

US 8604244

Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

granted A61PA61P25/24A61P3/04

Quick answer

US patent 8604244 (Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P25/24, A61P3/04